Literature DB >> 31627236

Cholemic Nephropathy Reloaded.

Peter Fickert1, Alexander R Rosenkranz2.   

Abstract

Acute kidney injury (AKI) is a dreaded complication in patients with liver disease and jaundice, since it is associated with significant morbidity and mortality. Cholemic nephropathy (CN) is thought to represent a widely underestimated important cause of AKI in advanced liver diseases with jaundice. The umbrella term CN describes impaired renal function along with histomorphological changes consisting of intratubular cast formation and tubular epithelial cell injury directed primarily toward distal nephron segments. In cholestasis, biliary constituents may be excreted via the kidney and bilirubin or bile acids may trigger tubular injury and cast formation, but as we begin to understand the underlying pathophysiologic mechanisms, we become increasingly aware of the urgent need for clearly defined diagnostic criteria. In the following, we aim to summarize current knowledge of clinical and morphological characteristics of CN, discuss potential pathomechanisms, and raise key questions to stimulate evolution of a research strategy for CN. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31627236     DOI: 10.1055/s-0039-1698826

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  7 in total

1.  Bile Acids Are Important Contributors to AKI Associated with Liver Disease: PRO.

Authors:  Peter Fickert; Alexander R Rosenkranz
Journal:  Kidney360       Date:  2021-05-03

2.  The activation of nuclear factor-E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling blunts cholestasis-induced liver and kidney injury.

Authors:  Khadijeh Mousavi; Hossein Niknahad; Huifeng Li; Zhipeng Jia; Ram Kumar Manthari; Yangfei Zhao; Xiong Shi; Yuanyu Chen; Asrin Ahmadi; Negar Azarpira; Bahman Khalvati; Mohammad Mehdi Ommati; Reza Heidari
Journal:  Toxicol Res (Camb)       Date:  2021-08-04       Impact factor: 2.680

Review 3.  Bile Cast Nephropathy: A Comprehensive Review.

Authors:  Manoj R Somagutta; Molly S Jain; Maria Kezia Lourdes Pormento; Siva K Pendyala; Narayana Reddy Bathula; Nagendrababu Jarapala; Ashwini Mahadevaiah; Nayana Sasidharan; Mohamed A Gad; Greta Mahmutaj; Namrata Hange
Journal:  Cureus       Date:  2022-03-29

4.  Silymarin mitigates bile duct obstruction-induced cholemic nephropathy.

Authors:  Mohammad Mehdi Ommati; Omid Farshad; Negar Azarpira; Elmira Ghazanfari; Hossein Niknahad; Reza Heidari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-02-04       Impact factor: 3.000

5.  Suppression of cirrhosis-related renal injury by N-acetyl cysteine.

Authors:  Narges Abdoli; Issa Sadeghian; Khadijeh Mousavi; Negar Azarpira; Mohammad Mehdi Ommati; Reza Heidari
Journal:  Curr Res Pharmacol Drug Discov       Date:  2020-10-13

6.  Pentoxifylline mitigates cholestasis-related cholemic nephropathy.

Authors:  Mohammad Mehdi Ommati; Sara Hojatnezhad; Narges Abdoli; Ram Kumar Manthari; Zhipeng Jia; Asma Najibi; Amin Reza Akbarizadeh; Issa Sadeghian; Omid Farshad; Negar Azarpira; Hossein Niknahad; Reza Heidari
Journal:  Clin Exp Hepatol       Date:  2021-11-25

7.  Characteristics of acute kidney injury and its impact on outcome in patients with acute-on-chronic liver failure.

Authors:  Yue Huang; Junjun Cai; Fushuang Ha; Beichen Guo; Shaojie Xin; Zhongping Duan; Tao Han
Journal:  BMC Gastroenterol       Date:  2022-05-11       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.